Literature DB >> 3402469

Acute right ventricular infarction secondary to massive pulmonary embolism.

I Coma-Canella1, C Gamallo, P Martinez Onsurbe, J Lopez-Sendon.   

Abstract

Isolated right ventricular infarction has been found in cases of right ventricular hypertrophy, but there are no reports on right ventricular infarction secondary to massive pulmonary embolism. Six autopsied patients with massive pulmonary embolism and pure right ventricular infarction, suspected to be secondary to the embolism, were selected from a population of 216 autopsies. Pulmonary embolism was the suspected diagnosis in five cases due to typical clinical, electrocardiographic and haemodynamic data. Right ventricular infarction was a post-mortem finding, not previously diagnosed. In every case the thickness of the right ventricular myocardium was normal. The necrosis of the right ventricle was transmural in four cases and subendocardial in two and the entire right ventricular wall (anterolateral as well as posterior) was involved. No mural thrombi were present and in no case did the necrosis involve the left ventricle. In one case the coronary arteries were normal, in the other five significant lesions of the right or left coronary arteries were observed. These lesions may have been, in part, responsible for the necrosis of the right ventricle when the massive pulmonary embolism was added. We conclude that right ventricular infarction may be secondary to pulmonary hypertension in the setting of massive pulmonary embolism, even in the absence of right ventricular hypertrophy and with normal or stenotic coronary arteries.

Entities:  

Mesh:

Year:  1988        PMID: 3402469     DOI: 10.1093/oxfordjournals.eurheartj.a062540

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  Correlation between ST-segment elevation and negative T waves in the precordial leads in acute pulmonary embolism: insights into serial electrocardiogram changes.

Authors:  Zhan Zhong-Qun; Yang Bo; Kjell C Nikus; Andrés Ricardo Pérez-Riera; Wang Chong-Quan; Wang Xian-Ming
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-11-08       Impact factor: 1.468

Review 2.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

3.  Long-term effects of acute pulmonary embolism on echocardiographic Doppler indices and functional capacity.

Authors:  M Ciurzyński; M Kurzyna; A Bochowicz; B Lichodziejewska; D Liszewska-Pfejfer; P Pruszczyk; A Torbicki
Journal:  Clin Cardiol       Date:  2004-12       Impact factor: 2.882

Review 4.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

Review 5.  Ischemia right ventricular dysfunction.

Authors:  J López-Sendón; E López de Sá; J L Delcán
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 6.  Right ventricular myocardial infarction and pulmonary embolism differential diagnosis--a challenge for the clinician.

Authors:  Carmen Ginghina; Geana-Alina Caloianu; Marinela Serban; Dinu Dragomir
Journal:  J Med Life       Date:  2010 Jul-Sep

7.  The emperor's new clothes: hypersensitivity of the new cardiac isoenzymes.

Authors:  Ma Ai Thanda Han; Vivek Cherian; R Dobbin Chow
Journal:  J Community Hosp Intern Med Perspect       Date:  2013-04-17

Review 8.  Challenges in high-sensitive troponin assay interpretation for intensive therapy.

Authors:  Humberto Andres Vaz; Raphael Boesche Guimaraes; Oscar Dutra
Journal:  Rev Bras Ter Intensiva       Date:  2019-02-28

9.  Prognostic value of Tpeak-Tend interval in patients with acute pulmonary embolism.

Authors:  Abdullah Icli; Mehmet Kayrak; Hakan Akilli; Alpay Aribas; Mukremin Coskun; Sumeyye Fatma Ozer; Kurtulus Ozdemir
Journal:  BMC Cardiovasc Disord       Date:  2015-09-03       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.